Kyle Jenne - EVP, Chf GL Pdt Str Ofcr at Ionis Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chf GL Pdt Str Ofcr
Stock Symbol
IONS on Nasdaq
All Insider Reports
All Insider Reports

Kyle Jenne - trading volume in the past year for Ionis Pharmaceuticals Inc

Holdings reported by Kyle Jenne for Ionis Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 36.7K $1.19M $32.32 Apr 15, 2025 Direct Common Stock
Performance Restricted Stock Units 18.7K $613K $32.81 Jan 15, 2025 Direct Common Stock
Common Stock 11.2K $318K $28.36 Apr 16, 2025 Direct
Non-Qualified Stock Option (right to buy) 18.7K Jan 2, 2025 Direct Common Stock

Transactions reported by Kyle Jenne for Ionis Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.